STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Zoetis (NYSE: ZTS) director Form 3 shows no current share or option holdings

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Zoetis Inc. director reports no share ownership in initial filing. A director of Zoetis Inc. (ZTS) filed an initial beneficial ownership statement on Form 3, indicating that they currently hold no non-derivative Zoetis securities, with Table I showing "No securities beneficially held" and an amount of 0. The filing also shows no derivative securities such as options or warrants listed in Table II. The form is filed by a single reporting person and is signed by an attorney-in-fact on their behalf.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tilenius Stephanie

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/01/2025
3. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
No securities beneficially held 0 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 12/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the latest Form 3 filing for Zoetis (ZTS) disclose?

The Form 3 discloses that a Zoetis Inc. director has filed an initial statement of beneficial ownership and currently reports no Zoetis securities beneficially held.

How many Zoetis (ZTS) shares does the reporting person currently own?

Table I of the filing states "No securities beneficially held" with an amount of 0 non-derivative Zoetis securities reported.

Does the Zoetis (ZTS) insider hold any options or other derivative securities?

Table II for derivative securities such as options, warrants, or convertible securities is present but contains no listed derivative positions for the reporting person.

What is the relationship of the reporting person to Zoetis (ZTS)?

The filing identifies the reporting person’s relationship to Zoetis Inc. as a Director, with no indication that they are a 10% owner or officer.

Is this Zoetis (ZTS) Form 3 filed by one or multiple reporting persons?

The document indicates that the Form is filed by one reporting person, not by a group.

Who signed the Zoetis (ZTS) Form 3?

The Form 3 is signed "/s/ Brenda Santuccio, as Attorney-in-Fact", indicating it was executed under a power of attorney for the reporting person.
Zoetis Inc

NYSE:ZTS

ZTS Rankings

ZTS Latest News

ZTS Latest SEC Filings

ZTS Stock Data

54.02B
440.24M
0.09%
98.66%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
PARSIPPANY